About Palomar Medical Technologies (NASDAQ:PMTI)
Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.
Industry, Sector and Symbol
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Palomar Medical Technologies (NASDAQ:PMTI) Frequently Asked Questions
What is Palomar Medical Technologies' stock symbol?
Palomar Medical Technologies trades on the NASDAQ under the ticker symbol "PMTI."
Who are Palomar Medical Technologies' key executives?
Palomar Medical Technologies' management team includes the folowing people:
- Joseph P. Caruso, Chairman of the Board, President, Chief Executive Officer (Age 54)
- Paul S. Weiner, Chief Financial Officer, Treasurer (Age 53)
- Louis P. Valente, Director (Age 81)
- Jeanne Cohane, Independent Director (Age 65)
- Damian N. Dell'Anno, Independent Director
- Nicholas P. Economou Ph.D., Independent Director (Age 63)
- James G. Martin Ph.D., Independent Director (Age 78)
Has Palomar Medical Technologies been receiving favorable news coverage?
News articles about PMTI stock have trended somewhat negative recently, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Palomar Medical Technologies earned a media sentiment score of -0.10 on Accern's scale. They also gave media coverage about the healthcare company an impact score of 47.60 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Palomar Medical Technologies?
Shares of PMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Palomar Medical Technologies' stock price today?
One share of PMTI stock can currently be purchased for approximately $13.41.
How big of a company is Palomar Medical Technologies?
Palomar Medical Technologies has a market capitalization of $267.90 million.
How can I contact Palomar Medical Technologies?
Palomar Medical Technologies' mailing address is 15 Network Drive, BURLINGTON, MA 1803, United States. The healthcare company can be reached via phone at +1-781-9932300.
MarketBeat Community Rating for Palomar Medical Technologies (PMTI)MarketBeat's community ratings are surveys of what our community members think about Palomar Medical Technologies and other stocks. Vote "Outperform" if you believe PMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Palomar Medical Technologies (NASDAQ:PMTI) Analyst Ratings History
(Data available from 4/26/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Palomar Medical Technologies (NASDAQ:PMTI) Earnings History and Estimates Chart
Palomar Medical Technologies (NASDAQ PMTI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/2/2013||Q1 2013||($0.01)||($0.06)||$20.30 million||$23.20 million||View||N/A|
|2/7/2013||Q4 2012||$0.04||$0.12||$22.70 million||$23.40 million||View||N/A|
Palomar Medical Technologies (NASDAQ:PMTI) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Palomar Medical Technologies (NASDAQ PMTI) Insider Trading and Institutional Ownership History
Palomar Medical Technologies (NASDAQ PMTI) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|6/12/2013||A Neil Pappalardo||Director||Sell||15,000||$13.45||$201,750.00|| |
|6/11/2013||Joseph P Caruso||CEO||Sell||21,711||$13.42||$291,361.62|| |
|6/7/2013||Joseph P Caruso||CEO||Sell||2,056||$13.47||$27,694.32|| |
|5/28/2013||Joseph P Caruso||CEO||Sell||40,000||$13.60||$544,000.00|| |
|5/24/2013||Joseph P Caruso||CEO||Sell||19,028||$13.58||$258,400.24|| |
|5/24/2013||Paul S Weiner||CFO||Sell||78,338||$13.59||$1,064,613.42|| |
|5/22/2013||Joseph P Caruso||CEO||Sell||20,000||$13.58||$271,600.00|| |
|5/17/2013||Joseph P Caruso||CEO||Sell||22,900||$13.58||$310,982.00|| |
|5/15/2013||Joseph P Caruso||CEO||Sell||70,000||$13.58||$950,600.00|| |
|5/14/2013||Paul S Weiner||CFO||Sell||40,485||$13.60||$550,596.00|| |
|5/9/2013||James G Martin||Director||Sell||14,756||$13.52||$199,501.12|| |
|11/15/2012||Broadwood Partners Lp||Major Shareholder||Buy||13,118||$7.19||$94,318.42|| |
Palomar Medical Technologies (NASDAQ PMTI) News Headlines
Palomar Medical Technologies (NASDAQ:PMTI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Palomar Medical Technologies (NASDAQ:PMTI) Income Statement, Balance Sheet and Cash Flow Statement
Palomar Medical Technologies (NASDAQ PMTI) Stock Chart for Thursday, April, 26, 2018